simvastatin has been researched along with Amyloid Angiopathy, Cerebral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacskai, BJ; Betensky, R; Borrelli, LA; Fine, S; Frosch, MP; Garcia-Alloza, M; Greenberg, SM; Lattarulo, C; Prada, C | 1 |
| Cao, D; Fukuchi, K; Kou, J; Li, L; Lim, JE; Pattanayak, A; Song, M; Yang, J | 1 |
2 other study(ies) available for simvastatin and Amyloid Angiopathy, Cerebral
| Article | Year |
|---|---|
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice.
Topics: Alkenes; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzene Derivatives; Cerebral Amyloid Angiopathy; Cyclic N-Oxides; Dipeptides; Fluorescent Dyes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Transgenic; Minocycline; Oxidative Stress; Presenilin-1; Protease Inhibitors; Reactive Oxygen Species; Simvastatin; Statistics as Topic; Stilbenes; Time Factors | 2009 |
Combined treatment of Aβ immunization with statin in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Alzheimer Vaccines; Amyloid beta-Peptides; Animals; Cerebral Amyloid Angiopathy; Disease Models, Animal; Female; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Simvastatin | 2012 |